Pedro J. del Nido

Last updated

Pedro J. del Nido is a Chilean pediatric cardiac surgeon who was the 95th president of the American Association for Thoracic Surgery (AATS), succeeding David J. Sugarbaker and preceding Joseph S. Coselli. [1]

Contents

Education

Del Nido completed medical school at University of Wisconsin Medical School, 1977, Madison, Wisconsin, his residency in General Surgery at Boston University 1982, Boston, Massachusetts, Residency in Cardiothoracic Surgery at Toronto General Hospital 1985, Toronto, Canada, and Fellowship in Pediatric Cardiothoracic Surgery at Hospital for Sick Children, 1986, Toronto, Canada. [2]

Cardioplegia

Del Nido is the eponym of the del Nido cardioplegia, a solution infused during open-heart surgery to temporarily stop the heart from beating, known as cardioplegic cardiac arrest. [3] Del Nido developed the solution while working at the University of Pittsburgh in the early 1990s, for which he subsequently received his first National Institutes of Health grant in 1992. [2] Del Nido cardioplegia has been in use for 28 years at Boston Children's Hospital. [4] While the del Nido cardioplegia was initially developed for use in pediatric patients, its use has gained popularity in adult cardiac surgery. [5]

Composition of del Nido cardioplegia [4]

Del Nido cardioplegia is a unique four-part crystalloid to one-part blood formulation that is typically dosed only one time. It consists of a base solution of Plasma-lyte A, which has an electrolyte composition similar to that of extracellular fluid. To one liter of Plasma-lyte A, the following are added to make the crystalloid component of del Nido cardioplegia:

Oxygenated whole blood is then added at a four-part crystalloid to one-part whole blood ratio, typically using the Heart-lung machine's circuit as it is delivered to the patient.

Mannitol

The purpose of the mannitol component is twofold: first, to scavenge oxygen free radicals and thus prevent myocardial injury during cardioplegic arrest and during subsequent reperfusion, and secondly, to reduce the myocardial edema implicated in post-ischemic myocardial impairment.

Magnesium Sulfate

The myocardial contraction-relaxation cycle, similar to other muscle, is closely reliant upon the intracellular calcium concentration. Magnesium is a calcium channel blocker, so its use in hypothermic cardioplegia improves ventricular recovery when coupled with a low calcium level.

Sodium Bicarbonate

Red blood cells contain a high concentration of an enzyme called Carbonic anhydrase, which facilitates the scavenging of excess hydrogen ions by combining them with bicarbonate to generate carbon dioxide and water. The sodium bicarbonate component of cardioplegia, in addition to its role in this reaction, as a buffering solution to assist in maintaining intracellular pH.

Potassium Chloride

A high concentration of potassium, known as hyperkalemia, is the most common arresting method for cardiac surgery. The potassium chloride component of cardioplegia provides a depolarized arrest.

Lidocaine

Lidocaine in cardioplegia serves as a sodium channel blocker and antiarrhythmic, which helps to prevent the accumulation of both sodium and calcium (through exchange mechanisms) inside the cell.

Patient Blood Additive

Del Nido cardioplegia is delivered with 20% by volume of fully oxygenated patient blood, supporting transient aerobic metabolism and providing buffering for anaerobic glycolysis, as well as improving coronary perfusion during cardioplegia delivery.

Related Research Articles

<span class="mw-page-title-main">Cardiac arrest</span> Sudden failure of heart beat

Cardiac arrest, also known as sudden cardiac arrest, is when the heart suddenly and unexpectedly stops beating. As a result, blood cannot properly circulate around the body and there is diminished blood flow to the brain and other organs. When the brain does not receive enough blood, this can cause a person to lose consciousness. Coma and persistent vegetative state may result from cardiac arrest. Cardiac arrest is also identified by a lack of central pulses and abnormal or absent breathing.

<span class="mw-page-title-main">Coronary artery bypass surgery</span> Surgical procedure to restore normal blood flow to an obstructed coronary artery

Coronary artery bypass surgery, also known as coronary artery bypass graft, is a surgical procedure to treat coronary artery disease (CAD), the buildup of plaques in the arteries of the heart. It can relieve chest pain caused by CAD, slow the progression of CAD, and increase life expectancy. It aims to bypass narrowings in heart arteries by using arteries or veins harvested from other parts of the body, thus restoring adequate blood supply to the previously ischemic heart.

<span class="mw-page-title-main">Rhabdomyolysis</span> Human disease (condition) in which damaged skeletal muscle breaks down rapidly

Rhabdomyolysis is a condition in which damaged skeletal muscle breaks down rapidly, often due to high intensity exercise over a short period of time. Symptoms may include muscle pains, weakness, vomiting, and confusion. There may be tea-colored urine or an irregular heartbeat. Some of the muscle breakdown products, such as the protein myoglobin, are harmful to the kidneys and can cause acute kidney injury.

<span class="mw-page-title-main">Cardiopulmonary bypass</span> Technique that temporarily takes over the function of the heart and lungs during surgery

Cardiopulmonary bypass (CPB) or heart-lung machine also called the pump or CPB pump is a machine that temporarily takes over the function of the heart and lungs during open-heart surgery by maintaining the circulation of blood and oxygen throughout the body. As such it is an extracorporeal device.

<span class="mw-page-title-main">Hyperkalemia</span> Medical condition with excess potassium

Hyperkalemia is an elevated level of potassium (K+) in the blood. Normal potassium levels are between 3.5 and 5.0 mmol/L (3.5 and 5.0 mEq/L) with levels above 5.5 mmol/L defined as hyperkalemia. Typically hyperkalemia does not cause symptoms. Occasionally when severe it can cause palpitations, muscle pain, muscle weakness, or numbness. Hyperkalemia can cause an abnormal heart rhythm which can result in cardiac arrest and death.

ATC code B05Blood substitutes and perfusion solutions is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup B05 is part of the anatomical group B Blood and blood forming organs.

<span class="mw-page-title-main">Electrolyte imbalance</span> Medical condition

Electrolyte imbalance, or water-electrolyte imbalance, is an abnormality in the concentration of electrolytes in the body. Electrolytes play a vital role in maintaining homeostasis in the body. They help to regulate heart and neurological function, fluid balance, oxygen delivery, acid–base balance and much more. Electrolyte imbalances can develop by consuming too little or too much electrolyte as well as excreting too little or too much electrolyte. Examples of electrolytes include calcium, chloride, magnesium, phosphate, potassium, and sodium.

<span class="mw-page-title-main">Hypovolemic shock</span> Medical condition

Hypovolemic shock is a form of shock caused by severe hypovolemia. It can be caused by severe dehydration or blood loss. Hypovolemic shock is a medical emergency; if left untreated, the insufficient blood flow can cause damage to organs, leading to multiple organ failure.

<span class="mw-page-title-main">Ringer's lactate solution</span> Fluid used for resuscitation after blood loss

Ringer's lactate solution (RL), also known as sodium lactate solution,Lactated Ringer's, and Hartmann's solution, is a mixture of sodium chloride, sodium lactate, potassium chloride, and calcium chloride in water. It is used for replacing fluids and electrolytes in those who have low blood volume or low blood pressure. It may also be used to treat metabolic acidosis and to wash the eye following a chemical burn. It is given by intravenous infusion or applied to the affected area.

Cardioplegia is a solution given to the heart during cardiac surgery, to minimize the damage caused by myocardial ischemia while the heart is paused.

<span class="mw-page-title-main">K. M. Cherian (doctor)</span> Indian heart surgeon

K. M. Cherian, in full Kotturathu Mammen Cherian, is an Indian heart surgeon. He performed India's first coronary artery bypass surgery and first heart Lung transplant. and is considered a pioneer of pediatric cardiac surgery in the country. He is also a former honorary surgeon to the President of India and a Padma Shri awardee.

Histidine-tryptophan-ketoglutarate, or Custodiol HTK solution, is a high-flow, low-potassium preservation solution used for organ transplantation. The solution was initially developed by Hans-Jürgen Bretschneider.

Iberiotoxin (IbTX) is an ion channel toxin purified from the Eastern Indian red scorpion Hottentotta tamulus. Iberiotoxin selectively inhibits the current through large-conductance calcium-activated potassium channels.

Cardiothoracic anesthesiology is a subspeciality of the medical practice of anesthesiology, devoted to the preoperative, intraoperative, and postoperative care of adult and pediatric patients undergoing cardiothoracic surgery and related invasive procedures.

The Hs and Ts is a mnemonic used to aid in remembering the possible reversible causes of cardiac arrest. A variety of disease processes can lead to a cardiac arrest; however, they usually boil down to one or more of the "Hs and Ts".

Minimally invasive cardiac surgery, encompasses various aspects of cardiac surgical procedures that can be performed with minimally invasive approach either via mini-thoracotomy or mini-sternotomy. MICS CABG or the McGinn technique is heart surgery performed through several small incisions instead of the traditional open-heart surgery that requires a median sternotomy approach. MICS CABG is a beating-heart multi-vessel procedure performed under direct vision through an anterolateral mini-thoracotomy.

<span class="mw-page-title-main">Intravenous sodium bicarbonate</span> Pharmaceutical drug

Intravenous sodium bicarbonate, also known as sodium hydrogen carbonate, is a medication primarily used to treat severe metabolic acidosis. For this purpose it is generally only used when the pH is less than 7.1 and when the underlying cause is either diarrhea, vomiting, or the kidneys. Other uses include high blood potassium, tricyclic antidepressant overdose, and cocaine toxicity as well as a number of other poisonings. It is given by injection into a vein.

<span class="mw-page-title-main">Rottlerin</span> Chemical compound

Rottlerin (mallotoxin) is a polyphenol natural product isolated from the Asian tree Mallotus philippensis. Rottlerin displays a complex spectrum of pharmacology.

Gerald Buckberg was an American surgeon. His research initially centered in the area of myocardial protection and led to the introduction of blood cardioplegia, which is currently used by over 85% of surgeons in the United States and 75% of surgeons worldwide for adult and pediatric heart operations. He was a member of multiple surgical societies, including the American Association for Thoracic Surgery, American Surgical Association, and the Society of Thoracic Surgeons. He was Professor of Surgery at the David Geffen School of Medicine at UCLA.

Joseph S. Coselli is an American cardiothoracic surgeon who was the 96th president of the American Association for Thoracic Surgery (AATS), succeeding Pedro J. del Nido and preceding Thoralf M. Sundt, III. Coselli is a Professor and Executive Vice Chair in the Department of Surgery and the Cullen Foundation Endowed Chair at the Baylor College of Medicine.

References

  1. ↑ "AATS Past Presidents". AATS. Retrieved 2022-09-23.
  2. 1 2 Spratt, John R.; Guleserian, Kristine J.; Shumway, Sara J. (February 2017). "Historical perspectives of The American Association for Thoracic Surgery: Pedro J. del Nido". The Journal of Thoracic and Cardiovascular Surgery. 153 (2): 225–227. doi: 10.1016/j.jtcvs.2016.10.011 . ISSN   1097-685X. PMID   27847163.
  3. ↑ Matte, Gregory S.; del Nido, Pedro J. (September 2012). "History and Use of del Nido Cardioplegia Solution at Boston Children's Hospital". The Journal of Extra-corporeal Technology. 44 (3): 98–103. ISSN   0022-1058. PMC   4557532 . PMID   23198389.
  4. 1 2 Matte, Gregory S.; del Nido, Pedro J. (September 2012). "History and use of del Nido cardioplegia solution at Boston Children's Hospital". The Journal of Extra-Corporeal Technology. 44 (3): 98–103. ISSN   0022-1058. PMC   4557532 . PMID   23198389.
  5. ↑ Marzouk, Mohamed; Lafreniere-Bessi, Valerie; Dionne, Stephanie; Simard, Serge; Pigeon, Christian; Dagenais, François; Ad, Niv; Jacques, Frederic (2020-05-08). "Transitioning to Del Nido cardioplegia for all-comers: the next switching gear?". BMC Cardiovascular Disorders. 20 (1): 215. doi: 10.1186/s12872-020-01506-0 . ISSN   1471-2261. PMC   7206735 . PMID   32384925.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.